QKS Group announced today that it has named Zimperium as a 2025 technology leader in the SPARK Matrixtm: In-App Protection, 2025. Ayush Patidar, Analyst at QKS Group, states, "Zimperium MAPS delivers ...

DelveInsight's "HEMLIBRA Market Size, Forecast, and Market Insight Report" highlights the details around HEMLIBRA, a ...

"The deal essentially gives WHO members more teeth in terms of their preparedness, response and prevention of future ...

Viking Therapeutics has multiple promising drugs in its portfolio that could generate billions in future revenue. Approval of VK2735 and VK2809 could lead to a surge in the stock's value.

Earlier in his career, Mr. Goodman also worked in business development at Spark Therapeutics and served as a management consultant at Easton Associates, a boutique life sciences consultancy. He holds ...

Earlier in his career, Mr. Goodman also worked in business development at Spark Therapeutics and served as a management consultant at Easton Associates, a boutique life sciences consultancy.

Confirmed speakers include Miguel Forte, CEO of Kiji Therapeutics; Thomas Carlsen ... every element is designed to spark meaningful connections, fresh insights and real collaboration." Applications to ...

Spark Therapeutics has reassured investors that its potentially revolutionary haemophilia B treatment won’t be de-railed by safety problems. The company hopes its lead treatment SPK-9001 can ...